Steven B. Ketchum, Ph.D.
Dr. Ketchum was elected to the board of directors in February 2012 after serving as Senior Vice President, Research and Development for Sunesis since 2008. Dr. Ketchum currently is the President of Research and Development, Senior Vice President at Amarin Corporation where he is responsible for Amarin’s drug discovery, preclinical and clinical development program and regulatory and medical affairs activities. At Sunesis, prior to Amarin, Dr. Ketchum, as a member of the Executive Committee, provided strategic direction for all facets of research and development, including clinical strategy and operations, regulatory affairs, and pharmaceutical development. Prior to Sunesis, Dr. Ketchum was Senior Vice President, Research and Development and Medical Affairs at Reliant Pharmaceuticals and prior to Reliant, Senior Vice President, Operations and Regulatory Affairs for IntraBiotics Pharmaceuticals, Inc. Dr. Ketchum also held positions with increasing responsibility in regulatory affairs during his nearly eight-year tenure at ALZA Corporation. Dr. Ketchum earned a Ph.D. in pharmacology from University College London and a B.S. in biological sciences from Stanford University.